TARA
NASDAQ
$4.07
Protara Therapeutics Inc (TARA)
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to identifying and promoting transformative therapies for the treatment of cancer and rare diseases. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $26.57 (+552.83%)
Market Cap
$227M
Free Cash Flow Yield
-27.79%
Beta (5Y)
1.08
Price Chart
Valuation
Market Cap$227M
P/B1.27
Profitability
EBITDA-$70M
EPS-$1.38
Financial Health
Free Cash Flow Yield-27.79%
Growth & Risk
EPS 5Y CAGR-19.06%
FCF 5Y CAGR+16.72%
Beta (5Y)1.08
Sharpe Ratio0.68